Huntingdon, United Kingdom

Neil A Castle


Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Huntingdon, GB (2001 - 2002)
  • Cary, NC (US) (2001 - 2023)

Company Filing History:


Years Active: 2001-2023

Loading Chart...
4 patents (USPTO):

Title: Neil A Castle: A Pioneer in Pharmaceutical Inventions

Introduction

Neil A Castle, an accomplished inventor based in Huntingdon, GB, has made significant contributions to the field of pharmaceuticals through his innovative work. With a total of four patents to his name, Castle's inventions focus on advancing medical treatments and improving patient outcomes.

Latest Patents

One of Castle's latest patents encompasses the invention of Imidazodiazepinediones and methods of use thereof. This patent reveals compounds following specific chemical formulas that are included in pharmaceutical compositions aimed at treating kidney diseases. Another notable patent is focused on Potassium Channel Inhibitors, detailing certain thiazolidinone and metathiazanone compounds. These compounds are instrumental as potassium channel inhibitors and hold promise for treating cardiac arrhythmias and various other medical conditions.

Career Highlights

Throughout his career, Neil A Castle has been associated with notable companies in the pharmaceutical sector, including Icagen, Inc. His work has contributed to the development of therapeutic methods that bolster health and enhance treatment protocols.

Collaborations

Castle has collaborated with several esteemed colleagues, including Michael F Gross and Jose Serafin Mendoza. These partnerships have fostered a dynamic exchange of ideas and have propelled the development of impactful pharmaceutical advancements.

Conclusion

Neil A Castle's innovative spirit and dedication to medical science have led to breakthroughs that not only exemplify his expertise as an inventor but also have the potential to change lives. His ongoing work continues to inspire fellow inventors and contributes significantly to the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…